ARTICLE | Clinical News
Debio 1450 regulatory update
September 22, 2014 7:00 AM UTC
Debiopharm said FDA granted Qualified Infectious Disease Product (QIDP) designation to Debio 1450 to treat acute bacterial skin and skin structure infections (ABSSSI). The small molecule prodrug inhib...